Slide Shows


10 Gene Therapy Companies Unignorable in 2019 The concept of gene therapy, which originated in the late 1960s, has come a long way – having had its own share of significant setbacks and gargantuan success.

10 RNA Therapeutics Companies To Watch In 2019 After decades of research and development in RNA interference (RNAi), considered one of the most exciting discoveries in biology, the year 2018 saw the first ever RNAi drug pass regulatory muster in the United States.

Biotech Stocks Facing FDA Decision In January 2019 As 2018 fades, it’s time to take a look at the drug candidates lined up at the FDA altar awaiting the federal agency’s decision in January 2019.

Supreme Cannabis Supreme Cannabis Company Inc. (FIRE.V) engages in the production of medical cannabis in Canada. The Toronto-based company was formerly known as Supreme Pharmaceuticals and changed its name to Supreme Cannabis Company, Inc. in December 2017. 7ACRES, the company’s wholly-owned subsidiary and flagship brand, is a federally licensed producer of cannabis operating inside a 342,000-square-foot facility in Kincardine, Ontario. It is en route to becoming Canada’s leading cultivator of consistently great commercial cannabis. In November, the company reported revenues for the first quarter of C$5.14 million, a 229 percent increase from the year-ago period’s C$1.56 million, and a 45 percent increase from the previous quarter.